Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026

Core Viewpoint - Organogenesis Holdings Inc. will report its fourth quarter and fiscal year 2025 financial results on February 26, 2026, after market close [1] Group 1: Financial Reporting - The financial results will be discussed in a conference call scheduled for 5:00 p.m. Eastern Time on February 26, 2026 [2] - The conference call will include a corporate update and a question and answer session for participants [2] Group 2: Company Overview - Organogenesis Holdings Inc. is a leading company in regenerative medicine, focusing on advanced wound care and surgical and sports medicine markets [3] - The company offers a comprehensive portfolio of innovative regenerative products to meet patient needs across the continuum of care [3]